Search Results - "Forloni G"

Review: PrP 106‐126 – 25 years after.

Authors: Forloni, G. Chiesa, R. Bugiani, O. et al.

Source: Neuropathology & Applied Neurobiology. Aug2019, Vol. 45 Issue 5, p430-440. 11p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease.

Authors: Epis R Marcello E Gardoni F et al.

Source: Brain: A Journal of Neurology; Nov2010, Vol. 133 Issue 11, p3323-3335, 13p

Neurochemical effects of minaprine, a novel psychotropic drug, on the central cholinergic system of the rat.

Authors: Garattini, S. Forloni, G. Tirelli, S. et al.

Source: Psychopharmacology. 1984, Vol. 82 Issue 3, p210-214. 5p.

This result is not displayed to guests.
Login for full access.

Insulin-like growth factor 1 receptor polymorphism rs2229765 and circulating interleukin-6 level affect male longevity in a population-based prospective study (Treviso Longeva- TRELONG)

Authors: Albani D Mazzuco S Polito L et al.

Source: Aging Male. Dec2011, Vol. 14 Issue 4, p257-264.

Peripheral inflammation exacerbates α‐synuclein toxicity and neuropathology in Parkinson's models.

Authors: La Vitola, P. Balducci, C. Baroni, M. et al.

Source: Neuropathology & Applied Neurobiology. Feb2021, Vol. 47 Issue 1, p43-60. 18p.

Neuronal cell adhesion genes and antidepressant response in three independent samples.

Authors: Fabbri, C Crisafulli, C Gurwitz, D et al.

Source: Pharmacogenomics Journal. Dec2015, Vol. 15 Issue 6, p538-548. 11p.

The TAT-JNK inhibitor peptide interferes with beta amyloid protein stability.

Authors: Colombo, A. Repici, M. Pesaresi, M. et al.

Source: Cell Death & Differentiation. Oct2007, Vol. 14 Issue 10, p1845-1848. 4p. 1 Graph.

Review article - Stem cell paracrine effect and delivery strategies for spinal cord injury regeneration.

Authors: Veneruso, V. Rossi, F. Villella, A. et al.

Source: Journal of Controlled Release. Apr2019, Vol. 300, p141-153. 13p.

Mesenchymal stem cells encapsulated into biomimetic hydrogel scaffold gradually release CCL2 chemokine in situ preserving cytoarchitecture and promoting functional recovery in spinal cord injury.

Authors: Papa, S. Vismara, I. Mariani, A. et al.

Source: Journal of Controlled Release. May2018, Vol. 278, p49-56. 8p.

Translational spectral electroencephalographic markers in the European PharmaCog project: a new resource for drug discovery for Alzheimer's disease.

Authors: Babiloni, C. Infarinato, F. Bastlund, J. F. et al.

Source: Proceedings of the Physiological Society. 2013, p210P-211P. 2p.

Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.

Authors: Galluzzi, S. Marizzoni, M. Babiloni, C. et al.

Source: Journal of Internal Medicine. Jun2016, Vol. 279 Issue 6, p576-591. 16p.

Replication Study to Confirm the Role of CYP2D6 Polymorphism rs1080985 on Donepezil Efficacy in Alzheimer's Disease Patients.

Authors: Albani D Martinelli Boneschi F Biella G et al.

Source: Journal of Alzheimer's Disease. 2012, Vol. 28 Issue 1, p745-749. 5p.